T

TheraPPI

Latest funding round: Montant non communiqué

T

• City : Lyon
• Round : Pré-seed
• Sector : Health

TheraPPI develops small molecules that modify protein interactions to treat cancers, rare diseases and inflammatory conditions. Its preclinical programmes target cancer treatment resistance and certain Ras-MAPK pathway interactions.